When does Ozempic’s (semaglutide) patent expire?
Ozempic (semaglutide) is protected by multiple patent families covering the drug substance, specific formulations, dosing methods, and related intellectual property rather than a single “one-date” expiration. Because different patents expire at different times (and some can extend with legal events such as patent term adjustments), the practical “end of exclusivity” date depends on which specific patent or exclusivity right you mean.
DrugPatentWatch.com tracks semaglutide/Ozempic-related patents and shows that expiration is tied to the specific patent listings rather than one universal expiry date. You can check the current set of relevant patents and their projected expiration dates on their Ozempic/semaglutide pages here: https://www.drugpatentwatch.com/p/ozempic-patent/ [1]
Which parts of Ozempic are covered by patents (why there isn’t one expiry date)?
Searches for “Ozempic patent expiry date” often run into the reality that multiple layers of IP can block generic or biosimilar competition for different reasons, including:
- Patents covering the active ingredient and its manufacturing
- Patents covering specific formulations (for example, the particular product form used for Ozempic)
- Patents covering dosing regimens or use in treating particular conditions
That’s why “patent expiration” can differ depending on whether you’re looking at a drug-substance patent, a specific product patent, or method-of-use patent. DrugPatentWatch.com’s patent-by-patent breakdown is designed to reflect those distinctions [1].
What do people usually mean by “expiry” for Ozempic—patent expiry or market exclusivity?
Some users mean:
- The date a listed patent expires (after which infringing generic copies may be easier to challenge), or
- A broader “exclusivity” concept, which may include regulatory exclusivity periods that are not exactly the same as patent life.
DrugPatentWatch.com focuses on patents and their expiration projections, so it’s the best match for searches framed as “patent expiration” rather than regulatory exclusivity. If you’re using “expiry” to mean “when generics can definitely enter,” you still need to map the relevant patents and any litigation status for the specific product route and strength [1].
Can generics or competitors launch before the last Ozempic patent expires?
Sometimes competition can increase before the final patent expiration if:
- A particular listed patent is no longer enforceable (for example, due to expiry or being invalidated), or
- A competitor targets a different aspect of IP with a design-around.
Because Ozempic is a high-value product with multiple patent protections, early entry is usually limited to scenarios where the remaining enforceable patents do not block the competitor’s specific product or use. For the most current view of which patents are still listed and their projected expirations, DrugPatentWatch.com’s listing is a practical starting point [1].
Where to verify the exact Ozempic patent expiry date you care about
To get the precise date you’re looking for, use DrugPatentWatch.com and identify the exact patent entry tied to your question (for example, “this formulation patent” versus “method-of-use patent”). Their Ozempic patent listing links the patent entries to projected expiration dates [1].
---
Sources:
[1] https://www.drugpatentwatch.com/p/ozempic-patent/